Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Contrast Induced Nephropathy in Oncology Patients With Sodium Bicarbonate

NCT00540904 is registered in ClinicalTrials.gov with Barretos Cancer Hospital as lead sponsor.

NCT NCT00540904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00540904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Contrast Induced Nephropathy in Oncology Patients With Sodium Bicarbonate
Lead sponsor
Barretos Cancer Hospital
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2007
Completion date
September 30, 2009
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

radiographic contrast agent nephropathy